Fulcrum Therapeutics (NASDAQ:FULC) is set to give its latest quarterly earnings report on Tuesday, 2024-02-27. Here’s what investors need to know before the announcement.
Analysts estimate that Fulcrum Therapeutics will report an earnings per share (EPS) of $-0.43.
Fulcrum Therapeutics bulls will hope to hear the company announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the …